Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Cancer Causes Control. 2012 Nov 10;24(1):81–89. doi: 10.1007/s10552-012-0092-x

Table 5.

Age- and multivariable-adjusteda HRs (95% CI) for breast cancer classified according to age at diagnosis and menopausal status at diagnosis (n=39,696)

No migraine (n=32,378) Any migraine (n=7,318)
Age-adjusted Multivariable-adjusted
No of cases HR (95% CI) No of cases HR (95% CI) HR (95% CI)
Age at diagnosis
 ≥ 50 yrs (n=66) 46 1.00 20 1.63 (0.96, 2.75)c 1.69 (1.00, 2.87)e
 > 50 yrs (n=2,212) 1,795 1.00 417 1.06 (0.96, 1.18)c 1.08 (0.97, 1.20)e
Postmenopausal status at diagnosisb
 Premenopausal (n=133) 101 1.00 32 1.22 (0.82, 1.82)d 1.38 (0.92, 2.06)f
 Postmenopausal (n=1,963) 1,595 1.00 368 1.08 (0.96, 1.21)d 1.10 (0.98, 1.23)f
a

Models were adjusted for age, BMI, alcohol consumption, smoking status, postmenopausal status, age at menarche, age at menopause, postmenopausal hormone use, hormone replacement therapy use, number of pregnancies, age at first pregnancy, family history of breast cancer, history of benign breast disease

b

182 women had dubious/unknown postmenopausal status and only contributed person-time

All p-value for heterogeneity were calculated using the Cochran's Q-Test.

c

p for heterogeneity: 0.12

d

p for heterogeneity: 0.54

e

p for heterogeneity: 0.10

f

p for heterogeneity: 0.29